Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
American Journal of Physiology. Renal Physiology|July 14, 2012
Circulating IL-6 mediates lung injury via CXCL1 production after acute kidney injury in miceNilesh Ahuja, Ana Andres-Hernando, Christopher Altmann, et al.
BMC Nephrology|August 2, 2013
Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney diseaseJelena Klawitter, Iram Zafar, Jost Klawitter, et al.
American Journal of Physiology. Renal Physiology|May 2, 2019
A study of sirolimus and mTOR kinase inhibitor in a hypomorphic <i>Pkd1</i> mouse model of autosomal dominant polycystic kidney diseaseSara J Holditch, Carolyn N Brown, Daniel J Atwood, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 9, 2013
NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injuryHyun-Jung Kim, Dong Won Lee, Kameswaran Ravichandran, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 2, 2015
CD4 T cell knockout does not protect against kidney injury and worsens cancerKameswaran Ravichandran, Qian Wang, Abdullah Ozkok, et al.
Journal of Proteome Research|October 13, 2012
Low-salt diet and cyclosporine nephrotoxicity: changes in kidney cell metabolismJelena Klawitter, Jost Klawitter, Volker Schmitz, et al.
Critical Care (London, England)|October 15, 2010
Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgeryPaula Dennen, Christopher Altmann, Jonathan Kaufman, et al.
Kidney International|January 20, 2012
Evaluation of urine biomarkers of kidney injury in polycystic kidney diseaseChirag R Parikh, Neera K Dahl, Arlene B Chapman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 20, 2012
Serum cystatin C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort studyAferdita Spahillari, Chirag R Parikh, Kyaw Sint, et al.
AAPS Open|August 29, 2025
Bardoxolone methyl improves survival and reduces clinical measures of kidney injury in tumor-bearing mice treated with cisplatinLauren E Thompson, Stacey M Tuey, Paola Garcia Gonzalez, et al.
Pageof 12